185 related articles for article (PubMed ID: 27738797)
1. Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemia.
Ganti BR; Marini BL; Nagel J; Bixby D; Perissinotti AJ
Support Care Cancer; 2017 Feb; 25(2):541-547. PubMed ID: 27738797
[TBL] [Abstract][Full Text] [Related]
2. Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
Przybylski DJ; Reeves DJ
Support Care Cancer; 2017 Dec; 25(12):3715-3721. PubMed ID: 28660351
[TBL] [Abstract][Full Text] [Related]
3. Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients.
Lee P; Knoebel RW; Pisano J; Pettit NN
J Oncol Pharm Pract; 2019 Apr; 25(3):758-761. PubMed ID: 29310512
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of levofloxacin prophylaxis against bacterial infection in pediatric patients with acute myeloid leukemia.
McCormick M; Friehling E; Kalpatthi R; Siripong N; Smith K
Pediatr Blood Cancer; 2020 Oct; 67(10):e28469. PubMed ID: 32710709
[TBL] [Abstract][Full Text] [Related]
5. Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions.
Lee SSF; Fulford AE; Quinn MA; Seabrook J; Rajakumar I
Support Care Cancer; 2018 May; 26(5):1499-1504. PubMed ID: 29170868
[TBL] [Abstract][Full Text] [Related]
6. A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
Yemm KE; Barreto JN; Mara KC; Dierkhising RA; Gangat N; Tosh PK
J Antimicrob Chemother; 2018 Jan; 73(1):204-211. PubMed ID: 29040595
[TBL] [Abstract][Full Text] [Related]
7. Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
Alexander S; Fisher BT; Gaur AH; Dvorak CC; Villa Luna D; Dang H; Chen L; Green M; Nieder ML; Fisher B; Bailey LC; Wiernikowski J; Sung L;
JAMA; 2018 Sep; 320(10):995-1004. PubMed ID: 30208456
[TBL] [Abstract][Full Text] [Related]
8. Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
Inaba H; Gaur AH; Cao X; Flynn PM; Pounds SB; Avutu V; Marszal LN; Howard SC; Pui CH; Ribeiro RC; Hayden RT; Rubnitz JE
Cancer; 2014 Jul; 120(13):1985-92. PubMed ID: 24677028
[TBL] [Abstract][Full Text] [Related]
9. Levofloxacin prophylaxis in hospitalized children with leukemia: A cost-utility analysis.
Maser B; Pelland-Marcotte MC; Alexander S; Sung L; Gupta S
Pediatr Blood Cancer; 2020 Oct; 67(10):e28643. PubMed ID: 32785971
[TBL] [Abstract][Full Text] [Related]
10. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Mayer K; Hahn-Ast C; Mückter S; Schmitz A; Krause S; Felder L; Bekeredjian-Ding I; Molitor E; Brossart P; von Lilienfeld-Toal M
Support Care Cancer; 2015 May; 23(5):1321-9. PubMed ID: 25617073
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of anti-fungal but not anti-bacterial prophylaxis in intensive primary AML therapy: a real-world, retrospective comparative single-centre study.
Gerber B; Köppel J; Paul M; Nguyen-Kim TD; Frauenfelder T; Nair G; Schanz U; Manz MG
Swiss Med Wkly; 2014; 144():w13985. PubMed ID: 25055166
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center.
Pohlen M; Marx J; Mellmann A; Becker K; Mesters RM; Mikesch JH; Schliemann C; Lenz G; Müller-Tidow C; Büchner T; Krug U; Stelljes M; Karch H; Peters G; Gerth HU; Görlich D; Berdel WE
Haematologica; 2016 Oct; 101(10):1208-1215. PubMed ID: 27470601
[TBL] [Abstract][Full Text] [Related]
13. Levofloxacin prophylaxis for pediatric leukemia patients: Longitudinal follow-up for impact on health care-associated infections.
Davis A; Stevens AM; Brackett J; Marquez L; Foster CE; Sauer HE; Campbell JR
Pediatr Blood Cancer; 2022 Jul; 69(7):e29525. PubMed ID: 35029328
[TBL] [Abstract][Full Text] [Related]
14. Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia.
Felsenstein S; Orgel E; Rushing T; Fu C; Hoffman JA
Pediatr Infect Dis J; 2015 Apr; 34(4):e78-84. PubMed ID: 25764103
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.
De Rosa FG; Motta I; Audisio E; Frairia C; Busca A; Di Perri G; Marmont F
BMC Infect Dis; 2013 Dec; 13():563. PubMed ID: 24289496
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy.
Ghadiany M; Rahimi H; Rezvani H; Mohammad Alizadeh A; Zamani N; Mehdizadeh M; Foratyazdi M
Asia Pac J Clin Oncol; 2016 Mar; 12(1):e11-5. PubMed ID: 24330539
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic use during cytarabine consolidation in acute myeloid leukemia.
Vale CA; Egan PC; Ingham R; Farmakiotis D; Reagan JL
Ann Hematol; 2021 Jan; 100(1):79-84. PubMed ID: 32870366
[TBL] [Abstract][Full Text] [Related]
18. [Levofloxacin prophylaxis in neutropenic patients].
Carena AA; Jorge L; Bonvehí P; Temporiti E; Zárate MS; Herrera F
Medicina (B Aires); 2016; 76(5):295-303. PubMed ID: 27723617
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
Ziegler M; Landsburg D; Pegues D; Bilker W; Gilmar C; Kucharczuk C; Gorman T; Bink K; Moore A; Fitzpatrick R; Stadtmauer EA; Mangan P; Kraus K; Han JH
Biol Blood Marrow Transplant; 2019 May; 25(5):1004-1010. PubMed ID: 30481595
[TBL] [Abstract][Full Text] [Related]
20. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
Ugarte-Torres A; Villasis-Keever A; Hernández-Bribiesca ME; Crespo-Solis E; Ruiz-Palacios GM; Sifuentes-Osornio J; Ponce-De-León-Garduño A
Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
